Mark Drummond Selected Research

Mark Drummond Research Topics

2	Splenomegaly 10/2021 - 01/2018
2	Primary Myelofibrosis (Myelosclerosis) 10/2021 - 01/2018
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2021 - 01/2016
1	Wernicke Encephalopathy (Wernicke's Encephalopathy) 10/2021
1	Anemia 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Essential Thrombocythemia 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 08/2003

1	fedratinibIBA 10/2021
1	Janus Kinase InhibitorsIBA 10/2021
1	ruxolitinibIBA 01/2018
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 01/2018
1	Janus Kinase 1IBA 01/2018
1	Janus Kinase 2IBA 01/2018
1	InterferonsIBA 01/2016
1	RG7388IBA 01/2016
1	Proto-Oncogene Proteins c-mdm2IBA 01/2016
1	Imatinib Mesylate (Gleevec)FDA Link 08/2003

1	Drug Therapy (Chemotherapy) 10/2021
1	Therapeutics 01/2018